O Impacto da COVID-19 no Diagnóstico de Doenças Cardíacas na América Latina Uma Subanálise do INCAPS COVID / The Impact of COVID-19 on Diagnosis of Heart Disease in Latin America an INCAPS COVID Sub-analysis

Resumo Fundamento A pandemia de COVID-19 interferiu na prestação de atendimento a doenças cardiovasculares na América Latina. No entanto, o efeito da pandemia nos volumes de procedimentos cardíacos diagnósticos ainda não foi quantificado. Objetivo Avaliar (1) o impacto de COVID-19 nos volumes de diagnóstico cardíaco na América Latina e (2) determinar sua relação com a incidência de casos de COVID-19 e as medidas de distanciamento social. Métodos A International Atomic Energy Agency realizou uma pesquisa mundial avaliando mudanças nos volumes diagnósticos cardíacos decorrentes da COVID-19. Foram obtidos os volumes diagnósticos cardíacos dos locais participantes para março e abril de 2020 e comparados com março de 2019. Foram coletados dados de distanciamento social a partir dos Relatórios de mobilidade da comunidade de Google e a incidência de COVID-19 por país a partir de Our World in Data. Resultados Foram realizadas pesquisas em 194 centros que realizam procedimentos diagnósticos cardíacos, em 19 países da América Latina. Em comparação com o mês de março de 2019, os volumes dos procedimentos diagnósticos cardíacos diminuíram 36% em março de 2020 e 82% em abril de 2020.As maiores reduções ocorreram em relação aos testes de estresse ecocardiográfico (91%), testes ergométricos de esteira (88%) e escore de cálcio por tomografia computadorizada (87%), com pequenas variações entre as sub-regiões da América Latina. As mudanças em padrões de distanciamento social (p < 0,001) estavam mais fortemente associadas com a redução do volume do que a incidência de COVID-19 (p = 0,003). Conclusões A COVID-19 foi associada a uma redução significativa de procedimentos diagnósticos cardíacos na América Latina, a qual foi mais relacionada ao distanciamento social do que ao aumento da incidência da COVID-19. São necessários melhor equilíbrio e timing de medidas de distanciamento social e planejamento para manter o acesso ao atendimento médico durante um surto pandêmico, especialmente em regiões com alta mortalidade cardiovascular.

Abstract Background The COVID-19 pandemic has disrupted the delivery of care for cardiovascular diseases in Latin America. However, the effect of the pandemic on the cardiac diagnostic procedure volumes has not been quantified. Objective To assess (1) the impact of COVID-19 on cardiac diagnostic volumes in Latin America and (2) determine its relationship with COVID-19 case incidence and social distancing measures. Methods The International Atomic Energy Agency conducted a worldwide survey assessing changes in cardiac diagnostic volumes resulting from COVID-19. Cardiac diagnostic volumes were obtained from participating sites for March and April 2020 and compared to March 2019. Social distancing data were collected from Google COVID-19 community mobility reports and COVID-19 incidence per country from the Our World in Data. Results Surveys were conducted in 194 centers performing cardiac diagnostic procedures, in 19 countries in Latin America. Procedure volumes decreased 36% from March 2019 to March 2020, and 82% from March 2019 to April 2020. The greatest decreases occurred in echocardiogram stress tests (91%), exercise treadmill tests (88%), and computed tomography calcium scores (87%), with slight variations between sub-regions of Latin America. Changes in social distancing patterns (p < 0.001) were more strongly associated with volume reduction than COVID-19 incidence (p = 0.003). Conclusions COVID-19 was associated with a significant reduction in cardiac diagnostic procedures in Latin America, which was more related to social distancing than to the COVID-19 incidence. Better balance and timing of social distancing measures and planning to maintain access to medical care is warranted during a pandemic surge, especially in regions with high cardiovascular mortality.

Imágenes híbridas de tomografía por emisión de positrones y resonancia magnética en el diagnóstico de la sarcoidosis cardíaca: experiencia piloto / Hybrid positron emission tomography and magnetic resonance imaging in cardiac sarcoidosis diagnosis: a pilot experience

RESUMEN Introducción: Estudios recientes sugieren combinar los hallazgos de la resonancia magnética cardíaca (RMC) y los de la tomografía por emisión de positrones (PET) para incrementar la sensibilidad del diagnóstico de la sarcoidosis cardíaca (SC). Objetivo: Evaluar el valor complementario de la RMC y la PET en el diagnóstico de la SC. Material y métodos: Entre diciembre 2018 y Julio 2020, 6 pacientes (4 hombres y 2 mujeres) fueron referidos a nuestro servicio con sospecha de SC para evaluación de inflamación del miocardio. Se efectuó un estudio de perfusión miocárdica en reposo (13N Amonio) y de 18F-Fluordesoxiglucosa (FDG)-PET para evaluar inflamación y/o fibrosis. A todos los pacientes se les realizó previamente una RMC con gadolinio. Resultados: La edad media fue de 60 ± 9 años. El 50% de los pacientes presentaban antecedente de sarcoidosis sistémica y el otro 50% sospecha de SC aislada. Ninguno de los pacientes presentó inflamación activa del miocardio por PET. Con la combinación de los patrones-PET y el realce por RMC se reclasificó a los pacientes: 50% tuvo menos del 10% de probabilidad de padecer SC y el otro 50% se clasificó como posible. Ninguno de los pacientes recibió tratamiento inmunosupresor. Conclusión: En nuestra población de pacientes con sospecha de SC e inflamación, realizamos un estudio PET luego de la RMC para calcular probabilidades de padecer SC. En ausencia de un patrón oro, se sugiere que el diagnóstico de SC se base en probabilidades de acuerdo a patrones de imágenes y cuadro clínico específicos.

ABSTRACT Background: Recent studies suggest combining the findings of cardiac magnetic resonance (CMR) and positron emission tomography (PET) to increase sensitivity in the diagnosis of cardiac sarcoidosis (CS). Objective: To evaluate the complementary value of CMR and PET in the diagnosis of CS. Methods: From December 2018 to July 2020, 6 patients (4 males and 2 females) with suspected CS were referred to our facility for evaluation of myocardial inflammation. A resting 13N Ammonia myocardial perfusion test and a 18F Fluorodeoxyglucose (FDG) PET were performed to evaluate myocardial inflammation and/or fibrosis. All patients had a previous gadoliniumenhanced CMR. Results: The average age was 60 ± 9 years. Fifty percent of the patients had a history of systemic sarcoidosis and the remaining 50% had suspected isolated CS. None of the patients had active myocardial inflammation based on the PET findings. With the combination of PET patterns and enhanced CMR, the patients were reclassified as follows: 50% had less than 10% chance of having CS and the other 50% was classified as possible cases of CS. None of the patients received immunosuppressants. Conclusion: In our patient population with suspected CS and inflammation, we conducted a PET study following a CMR to assess the potential for CS. In the absence of a gold standard, it is suggested that the diagnosis of CS should be based on probabilities according to specific imaging patterns and clinical features.

Imágenes en la amiloidosis cardíaca / Imaging in Cardiac Amyloidosis

RESUMEN La amiloidosis es un desorden sistémico producido por el depósito de fibrillas de proteínas insolubles que se pliegan y depositan en el miocardio. Los pacientes con amiloidosis y compromiso cardíaco tienen mayor mortalidad respecto a pacientes sin compromiso cardíaco. Las dos formas de amiloidosis más prevalentes que se asocian con compromiso cardíaco son la amiloidosis AL, por el depósito de las cadenas livianas de las inmunoglobulinas, y la amiloidosis ATTR, por el depósito de la proteína transtiretina (TTR) en forma mutada o senil. Este artículo tiene el objetivo de revisar las diferentes modalidades de imágenes cardíacas (ecocardiografía, resonancia magnética cardiaca, medicina nuclear y tomografía) que permiten determinar la severidad del compromiso cardíaco en pacientes con amiloidosis, el tipo de amiloidosis y su pronóstico. Finalmente, se sugiere un algoritmo diagnóstico para determinar el compromiso cardíaco en la amiloidosis adaptado a las herramientas diagnósticas disponibles localmente, con un enfoque práctico y clínico.

ABSTRACT Cardiac amyloidosis is a systemic disorder caused by the extracellular deposition of fibrils of insoluble proteins that misfold and deposit in the myocardium. Patients with amyloidosis and cardiac involvement have higher mortality rate than those without cardiac involvement. The two most prevalent types are amyloidosis with cardiac involvement are light-chain amyloidosis (AL) due to immunoglobulin light chain deposition and transthyretin amyloidosis (ATTR) due to deposition of mutated or senile forms of the transthyretin (TTR) protein. The aim of this paper is to review the different modalities of cardiac imaging tests (echocardiography, cardiac magnetic resonance imaging, nuclear medicine images and computed tomography scan) that can determine the severity of cardiac involvement in patients with amyloidosis, the type of amyloidosis and its prognosis. Finally, a diagnostic algorithm is proposed to determine cardiac involvement in amyloidosis, tailored to the diagnostic tools locally available with a practical and clinical approach.

Isquemia miocárdica sin lesiones coronarias obstructivas: MINOCA-INOCA: Revisión para la toma de decisiones GREECO (Grupo de Estudio de Enfermedades Coronarias) / Myocardial ischemia without coronary obstructions: MINOCA-INOCA. Review for decision making

Una de cada 4 coronariografías realizadas por isquemia miocárdica presenta lesiones menores al 50% Este dato desencadenó un creciente interés en la comunidad médica. La Sociedad Americana de Cardiología publicó recientemente un artículo que describe la posición consensuada de un grupo de expertos sobre la fisiopatología, el diagnóstico y el tratamiento de esta entidad. Nuestro trabajo refleja una revisión narrativa y la posición de un grupo de expertos pertenecientes a diferentes instituciones con servicios de Cardiología jerarquizados. Aborda aspectos fisiopatológicos y diagnósticos para comprender el enfoque actual del tratamiento, tanto en pacientes que ingresan con diagnóstico de MINOCA (infa rto de miocardio con lesiones angiográficas no graves) o de INOCA (angina e isquemia demostradas, pero sin lesiones coronarias que justifiquen este síndrome).

One in every four coronarographies performed to study myocardial ischemia shows coronary angiographic stenosis less than 50%. This data triggered an increasing interest in the medical community. The American Society of Cardiology recently published a position paper about the pathophysiology, diagnosis and treatment of this entity. Our group performed a narrative review reflecting the opinion of cardiology experts from different centers in Argentina. It aims physiopatologic and diagnostic aspect to understand the current approach in patients with MINOCA (myocardial infarction with non-obstructive coronary arteries) e INOCA (demonstrated angina and ischemia but without coronary lesions that justify this syndrome).

Relación entre los patrones de viabilidad, flujo miocárdico y la anatomía coronaria mediante tomografía por emisión de positrones integrada con tomografía multicorte / Relationship between Myocardial Viability, Myocardial Flow and Coronary Anatomy by Positron Emission Tomography Integrated with Multislice Computed Tomography

Introducción La relación entre la viabilidad, el flujo miocárdico y el grado de estenosis epicárdica en pacientes con enfermedad coronaria y disfunción ventricular izquierda está poco investigada. Objetivo Determinar si los patrones de viabilidad por tomografía por emisión de positrones (PET) y el flujo miocárdico en reposo se relacionan con el grado de estenosis epicárdica. Material y métodos Se evaluó la viabilidad en 27 pacientes mediante el análisis combinado de la perfusión con 13N-amonio (13NH3) y el metabolismo con 18F-fluoro-2-desoxiglucosa (FDG) para identificar cuatro patrones PET: match (hipocaptación concordante de ambos radiotrazadores), mismatch (hipoperfusión con captación preservada de FDG), mismatch inverso (perfusión preservada e hipocaptación de FDG) y perfusión/metabolismo conservados. El flujo absoluto se calculó mediante un modelo bicompartimental. Las estenosis se clasificaron en leves ( 50%), graves (> 70%) y críticas (= 90%). Resultados De 459 segmentos resultaron match el 33%, mismatch el 12%, mismatch inverso el 11% y conservado el 44%. El flujo para mismatch, mismatch inverso y conservado fue mayor que para los segmentos con match (p < 0,01). Quince lesiones fueron leves, 7 moderadas, 20 graves y 39 críticas. No hubo correlación entre el grado de estenosis y los patrones de viabilidad (R < 0,2; p = ns) ni con los valores de flujo (R = 0,12). El análisis por territorio vascular no mostró correlación con el grado de estenosis (p = ns). Conclusiones No hubo correlación entre los patrones PET, el grado de estenosis epicárdica y el flujo mio-cárdico, lo que sugiere que la anatomía coronaria no puede discriminar miocardio viable del necrótico ni predecir el estado del flujo miocárdico en pacientes con disfunción ventricular izquierda.

Background The relationship between myocardial viability, myocardial flow and the degree of epicardial coronary stenosis in patients with coronary artery disease and left ventricular dysfunction is unclear. Objective The purpose of this study is to determine whether positron emission tomography (PET) viability and myocardial flow at rest correlate with the degree of epicardial coronary stenosis. Methods Myocardial viability was evaluated in 27 patients by the combined analysis of 13N-Ammonia (13NH3) perfusion and 18F-fluoro-2-deoxyglucose (FDG) metabolism to identify four PET patterns: match (concordant reduced uptake of both radiotracers), mismatch (hypoperfusion with preserved FDG uptake), reverse mismatch (preserved perfusion and reduced FDG uptake) and preserved uptake of both radiotracers. Myocardial blood flow was calculated using a two-compartment model. Coronary artery stenosis was classified as mild (50%), severe (>70%) and critical (= 90%). Results From 459 analyzed segments, 33% were match, 12% mismatch, 11% reverse-mismatch and 44% preserved. Mismatch, reverse-mismatch and preserved patterns exhibited higher flows than the match pattern (p < 0.01). Fifteen coronary lesions were mild, 7 moderate, 20 severe and 39 critical. There was no correlation between the degree of coronary stenosis and viability patterns (R< 0.2, p=NS) or blood flow values (R=0.12). Analysis by vascular territory did not correlate with the degree of coronary stenosis (p=NS). Conclusions Lack of correlation between PET viability patterns, degree of epicardial stenosis and myocardial blood flow suggest that coronary anatomy can neither differentiate viable from necrotic myocardium nor predict the functional status of myocardial flow in patients with left ventricular dysfunction.

Evaluación de la Microcirculación: rol del SPECT y de la Tomografía por Emisión de Positrones / Evaluation of coronary microcirculation: Role of Spect and positron emission tomography

This investigation was designed to evaluate the coronary microcirculation and the role of single-photon emission computed tomography (SPECT) and positron emission tomografhy, for the detection of coronary artery stenosis and the evaluation of the physiological significance. Nuclear cardiology allows a not invasive manner of evaluation of the complete spectrum of the severity of the coronary artery disease (CAD). The study of the coronary microcirculation through the evaluation of the endothelial function and the coronary flow reserve permits the early detection of patients at risk for CAD. The evaluation of the coronary flow reserve associated to myocardial perfusion could have a potential role in patients with obstructive CAD, because is detects with higher precision the presence of CAD